Published
Innentüren, GCT, Ink VE 3029
Notice number: ocds-mnwr74-25940226
KEY INFORMATION
- Submission deadline
- • Nov 18, 2026
- Location
- 🇩🇪 Germany
- Contracting authority
- Charité - Universitätsmedizin Berlin
- Accepted Languages
- German
- Tender type
- Contract Value
- Published date
- Oct 16, 2026
TENDER DESCRIPTION
Charité — Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, is commissioning the new build for the Berlin Center for Gene and Cell Therapies on behalf of Gene and Cell Therapies Incubator Berlin GmbH (GCT). Description of the type and scope of the services Overall project: With the project Berlin Center for Gene and Cell Therapies, a modern new building with laboratory and office areas as well as GMP areas for a total of approx. 720 employees is being created at the southernmost part of the existing Bayer campus (Sellerstraße). The overall building consists of four usage areas: IQ Spaces Expansion, Co-Lab, incubator and GMP facility. The incubator area and the GMP production facility form the translation center. The laboratory and office areas that can be flexibly used in the incubator area will mainly be used by company founders (start-ups) who are particularly active in the field of research and development of cell and gene therapies. Space program: laboratories, offices, GMP area, lobby, café/bistro, logistics/warehousing Overall, approx. 5,700 m² of laboratory space together with adjoining office space will be planned; these will be distributed across floors 3 to 9.…
TENDER BRIEF
Login to view all answers and insights
Unlock tender brief for freeTENDER DOCUMENTS
DIRECTORY • 1 FILE
- n/aLINK
Login to view and download all tender documents
Unlock documents for freeASK AI ABOUT THIS TENDER
Can a foreign company apply?
Yes, foreign companies can apply as long as they meet all the requirements set out in the procurement documents.
Login to ask more questions.
Unlock AI tender chat for freeUnlock your tender workflow
Run your first search, evaluate the results, save a daily monitor and start building a pipeline of tenders worth pursuing.